AXS-05 Phase II Trial on Smoking Behavior

PHASE2CompletedINTERVENTIONAL
Enrollment

58

Participants

Timeline

Start Date

March 25, 2018

Primary Completion Date

March 31, 2019

Study Completion Date

March 31, 2019

Conditions
Smoking CessationSmoking, CigaretteNicotine Dependence
Interventions
DRUG

AXS-05

Dextromethorphan Immediate Release + Bupropion Sustained Release: Take 1 tablet two times per day, at least 8 hours apart and 1 hour prior to a meal, and 2 hours after a meal.

DRUG

Bupropion SR

Bupropion Sustained Release: Take 1 tablet two times per day, at least 8 hours apart and 1 hour prior to a meal, and 2 hours after a meal.

Trial Locations (1)

27705

Duke Center for Smoking Cessation, Durham

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Axsome Therapeutics, Inc.

INDUSTRY

lead

James Davis

OTHER